David Silberman

Insider Reports History

Entity
Individual
Location
20 Mamilla Avenue, Jerusalem, Israel
Signature
/s/ David Silberman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Silberman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ORAMED PHARMACEUTICALS INC. Chief Financial Officer Common Stock 367K $810K $2.21 Jan 4, 2024 Direct

Insider Reports Filed by David Silberman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ORMP ORAMED PHARMACEUTICALS INC. Jan 4, 2024 1 $0 4 Jan 8, 2024 Chief Financial Officer
ORMP ORAMED PHARMACEUTICALS INC. May 26, 2023 1 $0 4 May 31, 2023 Chief Financial Officer
ORMP ORAMED PHARMACEUTICALS INC. Apr 17, 2023 1 $0 4 Apr 20, 2023 Chief Financial Officer
ORMP ORAMED PHARMACEUTICALS INC. Jul 28, 2022 1 $0 4 Aug 1, 2022 Chief Financial Officer
ORMP ORAMED PHARMACEUTICALS INC. Jan 3, 2022 2 $0 4 Jan 5, 2022 Chief Financial Officer
ORMP ORAMED PHARMACEUTICALS INC. Sep 1, 2021 2 $0 4 Sep 2, 2021 Chief Financial Officer
ORMP ORAMED PHARMACEUTICALS INC. Jul 5, 2021 0 $0 3 Jul 8, 2021 Chief Financial Officer